UB Paderborn / Katalog / Suche / in CDI

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2018-01, Vol.19 (1), p.87-100

2018

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

Gene, 2021-08, Vol.793, p.145747-145747, Article 145747

2021

Link zum Volltext

Verfügbarkeit prüfen

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Genome medicine, 2022-08, Vol.14 (1), p.1-86, Article 86

2022

Link zum Volltext

Verfügbarkeit prüfen

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Cell Stress, 2019-03, Vol.3 (4), p.118-135

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessment of tumor suppressor promoter methylation in healthy individuals

Clinical epigenetics, 2020-08, Vol.12 (1), p.131-131, Article 131

2020

Link zum Volltext

Verfügbarkeit prüfen

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

Scientific reports, 2016-09, Vol.6 (1), p.33153, Article 33153

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of the CHEK2 R95 germline mutation

Hereditary cancer in clinical practice, 2016-09, Vol.14 (1), p.19-19, Article 19

2016

Link zum Volltext

Verfügbarkeit prüfen

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

Cancer & metabolism, 2019-06, Vol.7 (1), p.6-6, Article 6

2019

Link zum Volltext

Verfügbarkeit prüfen

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

Nature clinical practice. Oncology, 2006-07, Vol.3 (7), p.356-357

2006

Link zum Volltext

Verfügbarkeit prüfen

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions

Therapeutic Advances in Medical Oncology, 2012-05, Vol.4 (3), p.127-137

Lønning, Per E.

2012

Link zum Volltext

Verfügbarkeit prüfen

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

Translational oncology, 2017-10, Vol.10 (5), p.806-817

2017

Link zum Volltext

Verfügbarkeit prüfen

MDM2 Promoter SNP344TA (rs1196333) Status Does Not Affect Cancer Risk

PloS one, 2012-04, Vol.7 (4), p.e36263

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters

Molecular cancer, 2006-10, Vol.5 (1), p.47-47

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1792-1792

2013

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Nature genetics, 1999-11, Vol.23 (S3), p.69-69

1999

Link zum Volltext

Verfügbarkeit prüfen

Genomsekvensering for persontilpasset kreftbehandling

Tidsskrift for den Norske Lægeforening, 2012, Vol.132 (21), p.2406-2408

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT010: Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT010-CT010

2017

Link zum Volltext

Verfügbarkeit prüfen

Session 6 introduction

Breast cancer research : BCR, 2010-12, Vol.12 (Suppl 4), p.S15-S15, Article S15

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3704-3704

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1092-1092

2010

Link zum Volltext

Verfügbarkeit prüfen

A Mitochondrial Target Sequence Polymorphism in MnSOD Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Clinical cancer research, 2009-06, Vol.15 (12), p.4165-4173

2009

Link zum Volltext

Verfügbarkeit prüfen

Review of: Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

Breast cancer online, 2006-01, Vol.9 (1), p.1-3, Article e3

Lønning, P. E.

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer

The journal of clinical endocrinology and metabolism, 1996-06, Vol.81 (6), p.2216-2221

1996

Link zum Volltext

Verfügbarkeit prüfen

Expression Profiling of Breast Cancer: From Molecular Portraits to Clinical Utility

Oncogenomics, 2004, p.77-100

2004

Link zum Volltext

Verfügbarkeit prüfen

Foreword

Acta oncologica, 1996-01, Vol.35 (sup5), p.3-4

1996

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Assessment of tumor suppressor promoter methylation in healthy individuals

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

Prevalence of the CHEK2 R95 germline mutation

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

MDM2 Promoter SNP344TA (rs1196333) Status Does Not Affect Cancer Risk

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters

Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes

Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Genomsekvensering for persontilpasset kreftbehandling

Abstract CT010: Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor

Session 6 introduction

Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study

Abstract 1092: Alterations of the retinoblastoma gene in stage III breast cancers

A Mitochondrial Target Sequence Polymorphism in MnSOD Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Review of: Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer

Expression Profiling of Breast Cancer: From Molecular Portraits to Clinical Utility

Foreword

Aktive Filter

Suchergebnisse filtern